pre-IPO PHARMA

COMPANY OVERVIEW

VenatoRx is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant bacterial infections and hard-to-treat viral infections. Founded in 2010, VenatoRx has built a world-class in-house R&D organization that has filed over 100 patents spanning multiple research programs.


LOCATION

  • Malvern, PA, USA

  • THERAPEUTIC AREAS

  • Infectious Disease

  • WEBSITE

    http://www.venatorx.com/


    CAREER WEBSITE

    https://venatorx.applicantstack.com/x/openings


    SOCIAL MEDIA


    INVESTORS

    abingworth foresite-capital versant-ventures


    PRESS RELEASES


    Oct 20, 2022

    Venatorx Pharmaceuticals Presents Data on Investigational Cefepime-Taniborbactam at IDWeek 2022


    Oct 11, 2022

    Venatorx Pharmaceuticals to Present at IDWeek 2022


    Oct 3, 2022

    Venatorx Pharmaceuticals Awarded BARDA Project BioShield Contract


    Apr 4, 2022

    Venatorx Pharmaceuticals Raises Series C Financing Led by the AMR Action Fund


    Mar 10, 2022

    Venatorx Pharmaceuticals Announces Positive Results for Phase 3 Clinical Trial (CERTAIN-1) of Cefepime-Taniborbactam for Treatment of cUTI


    For More Press Releases


    Google Analytics Alternative